Jan Sunde

ORCID: 0000-0001-9855-2484 · 8 papers in corpus
review 2026
Pathology oncology research : POR ·doi:10.3389/pore.2026.1612281

The origin of ectopic gynecologic lesions has been debated since 1927, when Sampson first proposed retrograde menstruation as the underlying cause of endometriosis. Reproduction in mammals is an unusually permissive process, enabling the im…

article 2024
PloS one ·doi:10.1371/journal.pone.0292978

Endosalpingiosis (ES) and endometriosis (EM) refer to the growth of tubal and endometrial epithelium respectively, outside of their site of origin. We hypothesize that uterine secretome factors drive ectopic growth. To test this, we develop…

article 2023
·doi:10.1016/j.ajog.2022.11.461
preprint 2023
·doi:10.1101/2023.10.04.560850

Abstract Endosalpingiosis (ES) and endometriosis (EM) refer to the growth of tubal and endometrial epithelium respectively, outside of their site of origin. We hypothesize that uterine secretome factors drive ectopic growth. To test this, w…

article 2021
·doi:10.1158/1538-7445.am2021-lb248

Abstract OBJECTIVE: Develop a model of endosalpingiosis and endometriosis to investigate the mechanisms which facilitate implantation of exfoliated cells in the peritoneum. BACKGROUND: Endosalpingiosis (ES) and endometriosis (EM) are the gr…

article 2021
·doi:10.1016/j.ajog.2021.11.857
article 2020
·doi:10.1158/1538-7445.am2020-5798

Abstract High grade serous carcinoma (HGSC) arises from the ectopic implantation of malignant oviductal epithelial cells (OECs) in the peritoneal cavity and on the ovarian surface (the “tubal origins hypothesis”). We believe that these cell…

other 2020
PloS one ·doi:10.1371/journal.pone.0232487

Endosalpingiosis, traditionally regarded as an incidental pathological finding, was recently reported to have an association with gynecologic malignancies. To determine the prevalence of endosalpingiosis, we evaluated all benign appearing a…